Lista de obras - Lene Ryom - Dominio Público Uruguay

2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0.

scientific article published on 03 September 2020

A clinically useful risk-score for chronic kidney disease in HIV infection

artículo científico publicado en 2014

A comparison of estimated glomerular filtration rates using Cockcroft-Gault and the Chronic Kidney Disease Epidemiology Collaboration estimating equations in HIV infection

artículo científico publicado en 2013

Abacavir use and risk of recurrent myocardial infarction

artículo científico publicado en 2017

Advanced chronic kidney disease, end-stage renal disease and renal death among HIV-positive individuals in Europe

scientific article published on 16 April 2013

Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort

article

An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study

artículo científico publicado en 2015

Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study

artículo científico publicado en 2016

Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs study

artículo científico publicado en 2012

Antiretroviral therapy, immune suppression and renal impairment in HIV-positive persons

artículo científico publicado en 2014

Are we successfully managing cardiovascular disease in people living with HIV?

artículo científico publicado en 2017

Association Between ALT Level and the Rate of Cardio/Cerebrovascular Events in HIV-Positive Individuals

article

Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study

artículo científico publicado en 2013

Association between exposure to antiretroviral drugs and the incidence of hypertension in HIV-positive persons: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study

article

Associations between immune depression and cardiovascular events in HIV infection

artículo científico publicado en 2013

Associations between serum albumin and serious non-AIDS events among people living with HIV

article

Atazanavir is not associated with an increased risk of cardio or cerebrovascular disease events

Body Mass Index and the Risk of Serious Non-AIDS Events and All-Cause Mortality in Treated HIV-Positive Individuals

article

Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: the D: A: D study

artículo científico publicado en 2015

Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study

artículo científico publicado en 2017

Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study.

artículo científico publicado en 2018

Cessation of Cigarette Smoking and the Impact on Cancer Incidence in Human Immunodeficiency Virus–infected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study

article

Chronic Kidney Disease and Antiretroviral Therapy in HIV-Positive Individuals: Recent Developments

artículo científico publicado en 2016

Chronic kidney disease in patients with normal eGFR at baseline: results from EuroSIDA.

artículo científico publicado en 2010

Clinical outcomes of two-drug regimens vs. three-drug regimens in antiretroviral treatment-experienced people living with HIV

artículo científico publicado en 2020

Contemporary protease inhibitors and cardiovascular risk

artículo científico publicado en 2017

Contribution of Genetic Background and Data Collection on Adverse Events of Anti-human Immunodeficiency Virus (HIV) Drugs (D:A:D) Clinical Risk Score to Chronic Kidney Disease in Swiss HIV-infected Persons With Normal Baseline Estimated Glomerular F

scientific article published on 01 February 2020

Correction to: Clinical management of ageing people living with HIV in Europe: the view of the care providers

artículo científico publicado en 2020

Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study

artículo científico publicado en 2015

Deteriorating renal function and clinical outcomes in HIV-positive persons

artículo científico publicado en 2014

Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study

artículo científico publicado en 2015

Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: the D:A:D study

artículo científico publicado en 2014

Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin Lymphoma.

artículo científico publicado en 2017

Effect of changes in body mass index on the risk of cardiovascular disease and diabetes mellitus in HIV-positive individuals: results from the D: A: D study\

artículo científico publicado en 2020

Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV-positive persons

artículo científico publicado en 2015

Evaluation of HIV Protease Inhibitor Use and the Risk of Sudden Death or Nonhemorrhagic Stroke

article

Gender differences in HIV-positive persons in use of cardiovascular disease-related interventions: D:A:D study

artículo científico publicado en 2014

Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study

artículo científico publicado en 2018

HIV therapies and the kidney: some good, some not so good?

artículo científico

Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults

artículo científico publicado en 2012

Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0.

artículo científico publicado en 2018

Improvements over time in short-term mortality following myocardial infarction in HIV-positive individuals

artículo científico

Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations

artículo científico publicado en 2014

Influence of hepatitis C virus co-infection and hepatitis C virus treatment on risk of chronic kidney disease in HIV-positive persons

artículo científico publicado en 2020

Is nelfinavir exposure associated with cancer incidence in HIV-positive individuals?

artículo científico publicado en 2016

Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV? A cohort collaboration

artículo científico publicado en 2016

Kidney disease in antiretroviral-naïve HIV-positive adults with high CD4 counts: prevalence and predictors of kidney disease at enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

artículo científico publicado en 2015

Lack of association between use of efavirenz and death from suicide: evidence from the D:A:D study

artículo científico publicado en 2014

Longitudinal analysis of the associations between antiretroviral therapy, viraemia and immunosuppression with lipid levels: the D:A:D study

artículo científico publicado en 2016

Predictors of Ischemic and Hemorrhagic Strokes Among People Living With HIV: The D:A:D International Prospective Multicohort Study

scientific article published on 11 August 2019

Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive persons

artículo científico publicado en 2014

Predictors of estimated glomerular filtration rate progression, stabilization or improvement after chronic renal impairment in HIV-positive individuals

artículo científico publicado en 2017

Prevalence of impaired renal function in virologically suppressed people living with HIV compared with controls: the Copenhagen Comorbidity in HIV Infection (COCOMO) study

artículo científico publicado en 2019

Rapid Progression of Kidney Dysfunction in Swiss People Living with HIV: Contribution of Polygenic Risk Score and D:A:D Clinical Risk Score

artículo científico publicado en 2020

Renal Impairment and Cardiovascular Disease in HIV-Positive Individuals: The D:A:D Study

artículo científico publicado en 2016

Ritonavir-Boosted Protease Inhibitors Do Not Significantly Affect the Performance of Creatinine-Based Estimates of GFR

artículo científico publicado en 2020

Serious clinical events in HIV-positive persons with chronic kidney disease

scientific article published on 01 November 2019

Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study

artículo científico

The benefits and risks of PrEP and kidney function.

artículo científico publicado en 2016

The impact of immunosuppression on chronic kidney disease in people living with HIV; the D:A:D study

artículo científico publicado en 2020

The prevalence and predictive value of dipstick urine protein in HIV-positive persons in Europe

artículo científico publicado en 2014

Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration

artículo científico publicado en 2014

Uptake and Discontinuation of Integrase Inhibitors (INSTIs) in a Large Cohort Setting

scientific article published on 01 March 2020

Uptake and effectiveness of two-drug compared with three-drug antiretroviral regimens among HIV-positive individuals in Europe

scientific article published on 01 November 2019

Use of Contemporary Protease Inhibitors and Risk of Incident Chronic Kidney Disease in Persons With Human Immunodeficiency Virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study

artículo científico publicado en 2019

Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive persons

artículo científico publicado en 2016

Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting: The RESPOND cohort consortium

scientific article published on 31 December 2020

Lista de obras de Lene Ryom

2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0.

A clinically useful risk-score for chronic kidney disease in HIV infection

A comparison of estimated glomerular filtration rates using Cockcroft-Gault and the Chronic Kidney Disease Epidemiology Collaboration estimating equations in HIV infection

Abacavir use and risk of recurrent myocardial infarction

Advanced chronic kidney disease, end-stage renal disease and renal death among HIV-positive individuals in Europe

Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort

An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study

Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study

Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs study

Antiretroviral therapy, immune suppression and renal impairment in HIV-positive persons

Are we successfully managing cardiovascular disease in people living with HIV?

Association Between ALT Level and the Rate of Cardio/Cerebrovascular Events in HIV-Positive Individuals

Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study

Association between exposure to antiretroviral drugs and the incidence of hypertension in HIV-positive persons: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study

Associations between immune depression and cardiovascular events in HIV infection

Associations between serum albumin and serious non-AIDS events among people living with HIV

Atazanavir is not associated with an increased risk of cardio or cerebrovascular disease events

Body Mass Index and the Risk of Serious Non-AIDS Events and All-Cause Mortality in Treated HIV-Positive Individuals

Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: the D: A: D study

Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study

Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study.

Cessation of Cigarette Smoking and the Impact on Cancer Incidence in Human Immunodeficiency Virus–infected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study

Chronic Kidney Disease and Antiretroviral Therapy in HIV-Positive Individuals: Recent Developments

Chronic kidney disease in patients with normal eGFR at baseline: results from EuroSIDA.

Clinical outcomes of two-drug regimens vs. three-drug regimens in antiretroviral treatment-experienced people living with HIV

Contemporary protease inhibitors and cardiovascular risk

Contribution of Genetic Background and Data Collection on Adverse Events of Anti-human Immunodeficiency Virus (HIV) Drugs (D:A:D) Clinical Risk Score to Chronic Kidney Disease in Swiss HIV-infected Persons With Normal Baseline Estimated Glomerular F

Correction to: Clinical management of ageing people living with HIV in Europe: the view of the care providers

Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study

Deteriorating renal function and clinical outcomes in HIV-positive persons

Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study

Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: the D:A:D study

Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin Lymphoma.

Effect of changes in body mass index on the risk of cardiovascular disease and diabetes mellitus in HIV-positive individuals: results from the D: A: D study\

Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV-positive persons

Evaluation of HIV Protease Inhibitor Use and the Risk of Sudden Death or Nonhemorrhagic Stroke

Gender differences in HIV-positive persons in use of cardiovascular disease-related interventions: D:A:D study

Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study

HIV therapies and the kidney: some good, some not so good?

Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults

Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0.

Improvements over time in short-term mortality following myocardial infarction in HIV-positive individuals

Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations

Influence of hepatitis C virus co-infection and hepatitis C virus treatment on risk of chronic kidney disease in HIV-positive persons

Is nelfinavir exposure associated with cancer incidence in HIV-positive individuals?

Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV? A cohort collaboration

Kidney disease in antiretroviral-naïve HIV-positive adults with high CD4 counts: prevalence and predictors of kidney disease at enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

Lack of association between use of efavirenz and death from suicide: evidence from the D:A:D study

Longitudinal analysis of the associations between antiretroviral therapy, viraemia and immunosuppression with lipid levels: the D:A:D study

Predictors of Ischemic and Hemorrhagic Strokes Among People Living With HIV: The D:A:D International Prospective Multicohort Study

Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive persons

Predictors of estimated glomerular filtration rate progression, stabilization or improvement after chronic renal impairment in HIV-positive individuals

Prevalence of impaired renal function in virologically suppressed people living with HIV compared with controls: the Copenhagen Comorbidity in HIV Infection (COCOMO) study

Rapid Progression of Kidney Dysfunction in Swiss People Living with HIV: Contribution of Polygenic Risk Score and D:A:D Clinical Risk Score

Renal Impairment and Cardiovascular Disease in HIV-Positive Individuals: The D:A:D Study

Ritonavir-Boosted Protease Inhibitors Do Not Significantly Affect the Performance of Creatinine-Based Estimates of GFR

Serious clinical events in HIV-positive persons with chronic kidney disease

Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study

The benefits and risks of PrEP and kidney function.

The impact of immunosuppression on chronic kidney disease in people living with HIV; the D:A:D study

The prevalence and predictive value of dipstick urine protein in HIV-positive persons in Europe

Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration

Uptake and Discontinuation of Integrase Inhibitors (INSTIs) in a Large Cohort Setting

Uptake and effectiveness of two-drug compared with three-drug antiretroviral regimens among HIV-positive individuals in Europe

Use of Contemporary Protease Inhibitors and Risk of Incident Chronic Kidney Disease in Persons With Human Immunodeficiency Virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study

Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive persons

Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting: The RESPOND cohort consortium